The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction
Open accessAbstract
BACKGROUND/AIM: Plasma trimethylamine-N-oxide (TMAO), a product of intestinal microbial metabolism of dietary phosphatidylcholine has been recently associated with atherosclerosis and increased risk of cardiovascular diseases (CVD) in rodents and humans. However, the molecular mechanisms of how TMAO induces atherosclerosis and CVD progression are still unclear. The present study tested whether TMAO induces NLRP3 inflammasome formation and activation and thereby contributes to endothelial injury initiating atherogenesis. METHODS: Inflammasome formation and activation was determined by confocal microscopy, caspase-1 activity was measured by colorimetric assay, IL-1β production was measured using ELISA, cell permeability was determined by microplate reader and ZO-1 expression was determined by western blot analysis and confocal microscopy. In in vivo experiments, TMAO was infused by osmotic pump implantation. RESULTS: TMAO treatment significantly increased the colocalization of NLRP3 with Asc or NLRP3 with caspase-1, caspase-1 activity, IL-1β production, cell permeability in carotid artery endothelial cells (CAECs) compared to control cells. Pretreatment with caspase-1 inhibitor, WEHD or Nlrp3 siRNA abolished the TMAO-induced inflammasome formation, activation and cell permeability in these cells. In addition, we explored the mechanisms by which TMAO activates NLRP3 inflammasomes. TMAO-induced the activation of NLRP3 inflammasomes was associated with both redox regulation and lysosomal dysfunction. In animal experiments, direct infusion of TMAO in mice with partially ligated carotid artery were found to have increased NLRP3 inflammasome formation and IL-1β production in the intima of wild type mice. CONCLUSION: The formation and activation of NLRP3 inflammasomes by TMAO may be an important initiating mechanism to turn on the endothelial inflammatory response leading to endothelial dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another gut-derived metabolite, Trimethylamine N-oxide (TMAO), is primarily produced by the small intestinal microbiota from dietary precursors, including choline, betaine, carnitine, and deoxycarnitine, which are abundant in meat, eggs, and dairy products.”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [64]
In the citing paper
“TMAO has been implicated in cardiovascular diseases, contributing to platelet hyperreactivity, increased thrombosis risk, and endothelial dysfunction [63,64,65].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [64]
In the citing paper
“some trials performed in carotid artery endothelial cells (CAEC) revealed that TMAO significantly increases the activation and formation of NLRP3, caspase-1 activity, IL-1β production and cell permeability.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [89]
In the citing paper
“Recent investigations have suggested TMAO can impact inflammation via priming and activation of the NLRP3 inflammasome in endothelial cells, as well as the arterial vascular wall in mice, involving mitochondrial reactive oxygen species (ROS) production, thioredoxin interacting protein (TXNIP) and lysosomal destabilization87, 130, 131.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,760
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Flagged first, then by citations
Cited by
Sorted by citations
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Janeiro, M., Ramírez, M., Milagro, F., Martínez, J., & Solas, M. (2018) · Nutrients · doi:10.3390/nu10101398 · Cited by 631
Intestinal Microbiota in Cardiovascular Health and Disease
Tang, W. H. W., Bäckhed, F., Landmesser, U., & Hazen, S. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.024 · Cited by 524
Gut microbiota derived metabolites in cardiovascular health and disease
Wang, Z., & Zhao, Y. (2018) · Protein & Cell · doi:10.1007/s13238-018-0549-0 · Cited by 491
Mou, Y., Du, Y., Zhou, L., Yue, J., Hu, X., Liu, Y., Chen, S., Lin, X., Zhang, G., Xiao, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.796288 · Cited by 432
Lim, Y. J., Sidor, N. A., Tonial, N. C., Che, A., & Urquhart, B. L. (2021) · Toxins · doi:10.3390/toxins13020142 · Cited by 400
Yang, S., Li, X., Yang, F., Zhao, R., Pan, X., Liang, J., Tian, L., Li, X., Liu, L., Xing, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01360 · Cited by 360
Liu, Y., & Dai, M. (2020) · Mediators of Inflammation · doi:10.1155/2020/4634172 · Cited by 235
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
Canyelles, M., Borràs, C., Rotllán, N., Tondo, M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031940 · Cited by 218
Hu, R., Wang, M., Ni, S.-H., Wang, M., Liu, L., You, H., Wu, X., Wang, Y., Lu, L., & Wei, L. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172797 · Cited by 199
Arias, N., Arboleya, S., Allison, J., Kaliszewska, A., Higarza, S. G., Gueimonde, M., & Arias, J. L. (2020) · Nutrients · doi:10.3390/nu12082340 · Cited by 210
Ge, X., Zheng, L., Zhuang, R., Yu, P., Xu, Z., Liu, G., Xi, X., Zhou, X., & Fan, H. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz064 · Cited by 204
Ma, S., Tong, Q., Lin, Y., Pan, L., Fu, J., Peng, R., Zhang, X., Zhao, Z., Li, Y., Yu, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01027-6 · Cited by 197
Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease
Thomas, M. S., & Fernández, M. L. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00910-x · Cited by 192
Benson, T. W., Conrad, K. A., Li, X. S., Wang, Z., Helsley, R. N., Schugar, R. C., Coughlin, T. M., Wadding-Lee, C., Fleifil, S., Russell, H., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.060573 · Cited by 166
Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome
Li, X., Geng, J., Zhao, J., Ni, Q., Zhao, C., Zheng, Y., Chen, X., & Wang, L. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00866 · Cited by 164
Saaoud, F., Liu, L., Xu, K., Cueto, R., Shao, Y., Lu, Y., Sun, Y., Snyder, N. W., Wu, S., Yang, L., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.158183 · Cited by 156
Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect?
Papandreou, C., Moré, M. I., & Bellamine, A. (2020) · Nutrients · doi:10.3390/nu12051330 · Cited by 157
Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System
Falconi, C. A., Junho, C. V. C., Fogaça-Ruiz, F., Vernier, I. C. S., da Cunha, R. S., Stinghen, A. E. M., & Carneiro‐Ramos, M. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.686249 · Cited by 144
Wu, P., Chen, J., Chen, J., Tao, J., Wu, S., Xu, G., Wang, Z., Wei, D., & Yin, W. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29518 · Cited by 140
Chou, R., Chen, C., Chen, I., Huang, H.-L., Lu, Y., Kuo, C., Chang, C., Huang, P., Chen, J., & Lin, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40638-y · Cited by 135
Cheng, H., Liu, J., Tan, Y., Feng, W., & Peng, C. Y. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.10.003 · Cited by 140
Wang, Q., Shen, Y., Wang, X., Fu, S., Zhang, X., Zhang, Y., & Wang, R. (2020) · Aging · doi:10.18632/aging.102645 · Cited by 135
The Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation
Zhou, Y., Tong, Z., Jiang, S., Zheng, W., Zhao, J., & Zhou, X. (2020) · Cells · doi:10.3390/cells9051219 · Cited by 125
Gao, Q., Wang, Y., Wang, X., Fu, S., Zhang, X., Wang, R., & Zhang, X. (2019) · Aging · doi:10.18632/aging.102352 · Cited by 119
Fang, Q., Zheng, B., Liu, N., Liu, J., Liu, W., Huang, X., Zeng, X., Chen, L., Li, Z., & Ouyang, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.682482 · Cited by 116
Tan, Y., Sheng, Z., Zhou, P., Liu, C., Zhao, H., Song, L., Li, J., Zhou, J., Chen, Y., Wang, L., et al. (2019) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.118.007281 · Cited by 113
Witkowski, M., Witkowski, M., Friebel, J., Buffa, J. A., Li, X. S., Wang, Z., Sangwan, N., Li, L., DiDonato, J. A., Tizian, C., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab263 · Cited by 122
Praveenraj, S. S., Sonali, S., Anand, N., Hediyal, T. A., Vichitra, C., Kalyan, M., Kanna, P. V., Chandana, K. A., Paneyala, S., Mahalakshmi, A. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02990-5 · Cited by 116
Coptisine from Coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1
Wu, J., Luo, Y., Jiang, Q. Y., Li, S., Huang, W., Li, X., Liu, D., Hu, Y., Wang, P., Lü, X., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104348 · Cited by 100
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
Wang, B., Qiu, J., Lian, J., Yang, X., & Zhou, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.723886 · Cited by 109
High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction
Singh, G. B., Zhang, Y., Boini, K. M., & Koka, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143570 · Cited by 103
Self-citationGut microbiota and microbiota-derived metabolites in cardiovascular diseases
Chen, X., Zhang, H., Ren, S., Ding, Y.-N., Remex, N. S., Bhuiyan, M. S., Qu, J.-H., & Tang, X. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002206 · Cited by 101
Mosterd, C. M., Kanbay, M., van den Born, B. H., van Raalte, D. H., & Rampanelli, E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101484 · Cited by 96
Lee, Y., Nemet, I., Wang, Z., Lai, H. T. M., Otto, M. C. D. O., Lemaître, R. N., Fretts, A. M., Sotoodehnia, N., Budoff, M. J., DiDonato, J. A., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020646 · Cited by 95
Wang, Q., Guo, M., Liu, Y., Xu, M., Shi, L., Li, X., Zhao, J., Zhang, H., Wang, G., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14061222 · Cited by 97
Yao, M., Liao, P., Zhao, X., & Wang, L. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-01310-5 · Cited by 90
NLRP3 Inflammasome and Its Central Role in the Cardiovascular Diseases
Tong, Y., Wang, Z., Li, C., Lin, L., Liu, J., & Cheng, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4293206 · Cited by 92
Yin, W., Zhou, Q., OuYang, S.-X., Chen, Y., Gong, Y., & Liang, Y. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1506-8 · Cited by 88
Li, T., Gua, C., Wu, B., & Chen, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.069 · Cited by 89
Zhou, Y., Zhang, Y., Jin, S., Lv, J., Li, M., & Feng, N. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117031 · Cited by 94
Kapetanaki, S., Kumawat, A. K., Persson, K., & Demirel, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111864 · Cited by 80
Wang, M., Wang, Z., Lee, Y., Lai, H. T. M., Otto, M. C. D. O., Lemaître, R. N., Fretts, A. M., Sotoodehnia, N., Budoff, M. J., DiDonato, J. A., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316533 · Cited by 85
Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health
Caradonna, E., Abate, F., Schiano, E., Paparella, F., Ferrara, F., Vanoli, E., Difruscolo, R., Goffredo, V. M., Amato, B., Setacci, C., et al. (2025) · Metabolites · doi:10.3390/metabo15040220 · Cited by 93
Oktaviono, Y. H., Lamara, A. D., Saputra, P. B. T., Arnindita, J. N., Pasahari, D., Saputra, M. E., & Suasti, N. M. A. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.8893 · Cited by 92
Song, X., Dou, X., Chang, J., Zeng, X., Xu, Q., & Xu, C. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2414805 · Cited by 84
Role of the Microbiome in Gut-Heart-Kidney Cross Talk
Glorieux, G., Nigám, S. K., Vanholder, R. C., & Verbeke, F. (2023) · Circulation Research · doi:10.1161/circresaha.123.321763 · Cited by 80
Farhangi, M. A., Vajdi, M., & Asghari-Jafarabadi, M. (2020) · Nutrition Journal · doi:10.1186/s12937-020-00592-2 · Cited by 72
Chan, M. M.-Y., Yang, X., Wang, H., Saaoud, F., Sun, Y., & Fong, D. (2019) · Nutrients · doi:10.3390/nu11081821 · Cited by 68
Ilyas, A., Wijayasinghe, Y. S., Khan, I., Samaloty, N. M. E., Adnan, M., Dar, T. A., Poddar, N. K., Singh, L. R., Sharma, H., & Khan, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.964624 · Cited by 73
Shih, D. M., Zhu, W., Schugar, R. C., Meng, Y., Jia, X., Miikeda, A., Wang, Z., Zieger, M., Lee, R., Graham, M., et al. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312592 · Cited by 67
Hernandez, L. N., Ward, L. J., Arefin, S., Ebert, T., Laučytė-Cibulskienė, A., Collaborators, G.-F., Pilote, L., Norris, C. M., Raparelli, V., Kautzky‐Willer, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08387-7 · Cited by 70
Zhou, T., Xiang, D., Li, S., Yang, L., Gao, L., & Feng, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493042 · Cited by 68
Chamieh, C. E., Liabeuf, S., & Massy, Z. A. (2022) · Toxins · doi:10.3390/toxins14040280 · Cited by 69
Farhangi, M. A., & Vajdi, M. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1770199 · Cited by 60
The role of trimethylamine‐N‐Oxide in the development of Alzheimer's disease
Buawangpong, N., Pinyopornpanish, K., Siri‐Angkul, N., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30646 · Cited by 59
The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison
Evans, M., Dai, L., Avesani, C. M., Kublickiene, K. R., & Stenvinkel, P. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad095 · Cited by 68
TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies
Zhang, W., Wang, Y., Zhang, A., Ding, Y., Zhang, X., Jia, Q.-J., Zhu, Y., Li, Y., Lv, S., & Zhang, J. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10115-x · Cited by 59
Inflammatory Mediators in Atherosclerotic Vascular Remodeling
Evans, B. R., Yerly, A., van der Vorst, E. P. C., Baumgärtner, I., Bernhard, S., Schindewolf, M., & Döring, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.868934 · Cited by 60
DiNicolantonio, J. J., McCarty, M. F., & O’Keefe, J. H. (2019) · Open Heart · doi:10.1136/openhrt-2018-000890 · Cited by 59
Tan, C., Wang, H., Gao, X., Xu, R., Zeng, X., Cui, Z., Zhu, J., Wu, Q., Xia, G., Zhou, H., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00029 · Cited by 55
Bai, Y., Mu, Q., Bao, X., Zuo, J., Fang, X., Hua, J., Zhang, D., Jiang, G., Li, P., Gao, S., et al. (2021) · Aging and Disease · doi:10.14336/ad.2021.0318 · Cited by 56
Self-citationTang, Y., Wa, Q., Peng, L., Zheng, Y., Chen, J., Chen, X., Zou, X., Shen, H., & Huang, S. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8332825 · Cited by 52
Voigt, R. M., Wang, Z., Brown, J. M., Engen, P. A., Naqib, A., Goetz, C. G., Hall, D. A., Metman, L. V., Shaikh, M., Forsyth, C. B., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105780 · Cited by 51
Zhong, J., Yu, R., Zhou, Q., Liu, P., Liu, Z., & Bian, Y. (2021) · Food & Function · doi:10.1039/d1fo00155h · Cited by 51
The Nutritional Supplement L-Alpha Glycerylphosphorylcholine Promotes Atherosclerosis
Wang, Z., Hazen, J. E., Jia, X., Org, E., Zhao, Y., Osborn, L. J., Nimer, N. A., Buffa, J. A., Culley, M. K., Krajcik, D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413477 · Cited by 52
Li, Y., Lü, H., Guo, J., Zhang, M., Zheng, H., Liu, Y., & Liu, W. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2215542 · Cited by 54
Prognostic Value of Plasma Trimethylamine N-Oxide Levels in Patients with Acute Ischemic Stroke
Zhai, Q., Wang, X., Chen, C., Tang, Y., Wang, Y., Tian, J., Zhao, Y., & Liu, X. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00714-3 · Cited by 53
Gut microbiota dependant trimethylamine N-oxide and hypertension
Mutengo, K. H., Masenga, S. K., Mweemba, A., Mutale, W., & Kirabo, A. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1075641 · Cited by 53
Cho, Y.-J., Lee, H. G., Seo, K., YOKOYAMA, W. H., & Kim, H. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03720 · Cited by 50
El‐Deeb, O. S., Atef, M. M., & Hafez, Y. M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28707 · Cited by 52
Deng, Y., Zou, J., Hong, Y., Peng, Q., Fu, X., Duan, R., Chen, J., & Chen, X. (2022) · Cells · doi:10.3390/cells11223650 · Cited by 48
He, Z., Kwek, E., Hao, W., Zhu, H., Liu, J., Ma, K. Y., & Chen, Z. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-020-00535-y · Cited by 51
Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases
Tan, J., Taitz, J., Nanan, R. K. H., Grau, G. E., & Macia, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015256 · Cited by 58
Dong, Z., Liang, Z., Guo, M., Hu, S., Shen, Z., & Hai, X. (2018) · Disease Markers · doi:10.1155/2018/1578320 · Cited by 51
Small Molecule Metabolites at the Host–Microbiota Interface
Bishai, J. D., & Palm, N. W. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100528 · Cited by 50
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO
Tu, R., & Xia, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230203140805 · Cited by 47
Farhangi, M. A., & Vajdi, M. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa111 · Cited by 50
Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases
He, S., Jiang, H., Zhuo, C., & Jiang, W. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-021-09656-z · Cited by 46
The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders
Młynarska, E., Barszcz, E., Budny, E., Gajewska, A., Kopeć, K., Wasiak, J., Rysz, J., & Franczyk, B. (2025) · Nutrients · doi:10.3390/nu17071135 · Cited by 44
He, Z., Hao, W., Kwek, E., Lei, L., Liu, J., Zhu, H., Ma, K. Y., Zhao, Y., Ho, H., He, W., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06753 · Cited by 46
Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis
Jang, J. W., Capaldi, E., Smith, T. L., Verma, P., Varga, J., & Ho, K. J. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00895-8 · Cited by 48
Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation
Iglesias‐Carres, L., Hughes, M. D., Steele, C. N., Ponder, M. A., Davy, K. P., & Neilson, A. P. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108600 · Cited by 43
Lu, H., You, Y., Zhou, X., He, Q., Wang, M., Chen, L., Zhou, L., Sun, X., Liu, Y., Jiang, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.774433 · Cited by 43
Wu, Y., Rong, X., Pan, M., Wang, T., Yang, H., Chen, X., Xiao, Z., & Zhao, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.840171 · Cited by 42
Krueger, E. S., Lloyd, T. S., & Tessem, J. S. (2021) · Nutrients · doi:10.3390/nu13082873 · Cited by 41
Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease
Yan, Z., Wang, G., & Shi, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.785375 · Cited by 49
Trimethylamine-N-oxide and cerebral stroke risk: A review
Dolkar, P., Deyang, T., Anand, N., Rathipriya, A. G., Hediyal, T. A., Vichitra, C., Krishnamoorthy, N. K., Gorantla, V. R., Bishir, M., Rashan, L. J., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106423 · Cited by 46
Role of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead
Datta, S., Pasham, S., Sandeep, I. S., Boini, K. M., & Koka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810208 · Cited by 42
Self-citationChen, C., Leu, H., Wang, S., Tsai, S., Chou, R., Lu, Y., Tsai, Y., Kuo, C., Huang, P., Chen, J., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0115 · Cited by 41
Gut Enterobacteriaceae and uraemic toxins - Perpetrators for ageing
Boopathi, S., Kumar, R. M. S., Priya, P. S., Haridevamuthu, B., Nayak, S. P. R. R., Chulenbayeva, L., Kushugulova, A. R., & Arockiaraj, J. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112088 · Cited by 40
Intestinal barrier dysfunction as a key driver of severe COVID-19
Tsounis, E. P., Triantos, C. K., Konstantakis, C., Marangos, M. N., & Assimakopoulos, S. F. (2023) · World Journal of Virology · doi:10.5501/wjv.v12.i2.68 · Cited by 39
Hou, L., Zhang, Y., Zheng, D., Shi, H., Zou, C., Zhang, H., Lü, Z., & Du, H. (2020) · Neurological Research · doi:10.1080/01616412.2019.1710416 · Cited by 40
Vascular Cognitive Impairment and the Gut Microbiota
Li, S., Shao, Y., Li, K., HuangFu, C., Wang, W., Liu, Z., Cai, Z., & Zhao, B. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171103 · Cited by 40
Impact of trimethylamine N-oxide (TMAO) metaorganismal pathway on cardiovascular disease
Zhao, Y., & Wang, Z. (2020) · Journal of Laboratory and Precision Medicine · doi:10.21037/jlpm.2020.01.01 · Cited by 42
Metabolic adaptations of cells at the vascular-immune interface during atherosclerosis
Bonacina, F., Dalt, L. D., Catapano, A. L., & Norata, G. D. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100918 · Cited by 37
Lian, D., Lai, J., Wu, Y., Wang, L., Chen, Y., Zhang, Y., Boini, K. M., Huang, Y., & Chen, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494656 · Cited by 36
Self-citationWu, X., Chen, L., Zeb, F., Huang, Y., An, J., Ren, J., Yang, F., & Feng, Q. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.05.032 · Cited by 38
Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease
Sharpton, S. R., Yong, G. J. M., Terrault, N. A., & Lynch, S. V. (2018) · Hepatology Communications · doi:10.1002/hep4.1284 · Cited by 37
Sirtuins family as a target in endothelial cell dysfunction: implications for vascular ageing
Zhang, H., Dai, Y., Zhang, C., Alfred, M. O., Ghosh, A., Khanra, I., Chakraborty, M., Yu, X., & Liang, J. L. (2020) · Biogerontology · doi:10.1007/s10522-020-09873-z · Cited by 35
Metadata
- Authors
- Boini, K. M., Hussain, T., Li, P.-L., & Koka, S. S.
- Affiliations
- University of Houston (US)
- Virginia Commonwealth University (US)
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 44
- Issue
- 1
- Pages
- 152-162
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- PMC
- PMC5828122
- OpenAlex
- W2767806634
- Semantic Scholar
- de8ac468d4e798c06de304d9dfc8cf3df3a51462
- Cited by
- 302
- References
- 60
- Citations by year
- 2026: 38 · 2025: 38 · 2024: 38 · 2023: 46 · 2022: 38 · 2021: 39 · 2020: 26 · 2019: 25 · 2018: 13 · 2017: 1
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cellular Physiology and Biochemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL075316, R01HL057244)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK104031)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- trimethylamine N-oxide, NLRP3 inflammasome, endothelial dysfunction, atherosclerosis, caspase-1, IL-1β, endothelial permeability, redox regulation, lysosomal dysfunction, cardiovascular disease, gut microbiota
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Amino Acid Chloromethyl Ketones, Animals, Carotid Arteries, Cells, Cultured, Male, Methylamines, Mice, Inbred C57BL, Microscopy, Fluorescence, Permeability, Signal Transduction, Caspase 1, RNA Interference, RNA, Small Interfering, Endothelial Cells, Mice, Interleukin-1beta, Inflammasomes, Caspase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review